Suzhou Ribo Life Science Co., Ltd. (HKG:6938)

Suzhou Ribo Life Science Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018
Cash & Equivalents	406.75	183.62	212.35	238.12	105.11
Short-Term Investments	1.59	1.54	2.92	-	-
Cash & Short-Term Investments	408.34	185.16	215.27	238.12	105.11
Cash Growth	120.53%	-13.98%	-9.60%	126.55%	-51.45%
Accounts Receivable	5.46	3.47	0.01	-	-
Other Receivables	30.52	31.28	38.58	0.92	1.46
Receivables	35.98	34.75	38.59	0.92	1.46
Inventory	54.93	42.72	45.6	19.87	10.17
Other Current Assets	17.8	6.66	10.02	20.87	8.24
Total Current Assets	517.05	269.29	309.48	279.79	124.98
Property, Plant & Equipment	245.04	276.1	296.79	44.83	29.36
Other Intangible Assets	76.83	92.47	108.42	88.49	99.86
Other Long-Term Assets	0.89	12.99	1.57	18.96	14.63
Total Assets	839.81	650.86	716.25	432.07	268.82

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018
Accounts Payable	11.63	24.23	23.27	5.61	6.71
Accrued Expenses	37.49	26.13	26.51	12.33	7.09
Short-Term Debt	-	12.43	12.1	76.08	-
Current Portion of Long-Term Debt	373.03	214.18	205.18	-	-
Current Portion of Leases	12.06	7.63	8.09	-	-
Current Income Taxes Payable	1.44	1.24	-	0.62	0.38
Current Unearned Revenue	78.99	81.02	14.49	12.28	10.27
Other Current Liabilities	86.78	47.46	38.21	2.93	2.09
Total Current Liabilities	601.41	414.31	327.85	109.85	26.53
Long-Term Debt	149.38	172.28	163.71	-	-
Long-Term Leases	15.6	22.36	25.66	-	-
Long-Term Unearned Revenue	32.88	89.7	24.15	0.88	1.64
Other Long-Term Liabilities	13.76	63.28	59.16	9.75	-
Total Liabilities	813.04	761.93	600.53	120.49	28.17

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018
Common Stock	134.2	129.61	128.39	29.81	27.04
Additional Paid-In Capital	1,557	1,283	1,046	683.49	480.52
Retained Earnings	-1,800	-1,522	-1,252	-400.37	-266.01
Comprehensive Income & Other	14.41	-0.88	182.34	-	-
Total Common Equity	-93.94	-110.36	105.1	312.93	241.55
Minority Interest	120.71	-0.71	10.62	-1.35	-0.9
Shareholders' Equity	26.77	-111.07	115.72	311.58	240.65
Total Liabilities & Equity	839.81	650.86	716.25	432.07	268.82

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018
Total Debt	550.07	428.88	414.74	76.08	-
Net Cash (Debt)	-141.73	-243.72	-199.47	162.04	105.11
Net Cash Growth	-	-	-	54.16%	-51.45%
Net Cash Per Share	-1.07	-1.89	-1.55	5.44	3.89
Filing Date Shares Outstanding	134.2	134.2	128.39	29.81	27.04
Total Common Shares Outstanding	134.2	129.61	128.39	29.81	27.04
Working Capital	-84.36	-145.01	-18.38	169.94	98.45
Book Value Per Share	-0.70	-0.85	0.82	10.50	8.93
Tangible Book Value	-170.77	-202.83	-3.32	224.45	141.69
Tangible Book Value Per Share	-1.27	-1.56	-0.03	7.53	5.24
Buildings	121.74	128.17	128.17	-	-
Machinery	173.51	169.47	161.97	71.13	48.46
Leasehold Improvements	4.28	4.28	4.28	-	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 28, 2026

Data Sources Report a data error